Objetivo: This health technology assessment looked at the effectiveness, safety, cost-effectiveness, budget impact, and patient experiences of transcatheter aortic valve implantation (TAVI) compared with surgical aortic valve replacement (SAVR) in patients with severe, symptomatic aortic valve stenosis at intermediate surgical risk.
